In conclusion, our study demonstrates that inhibition of the BET proteins attenuates microglial activation and neuronal damage in vitro, providing a potential therapeutic avenue for mitigating neuro-inflammatory degeneration in neurodegenerative diseases, such as Alzheimer’s disease. Here, DNER is linked to neurodegenerative disease.